BID and the α-bisabolol-triggered cell death program: converging on mitochondria and lysosomes.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 12, p. 1, doi. 10.1038/s41419-019-2126-8
- By:
- Publication type:
- Article
Works matching AU Sissa, Cinzia
Results: 8
1
2
ABO blood group and von Willebrand factor: biological implications.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2014, v. 52, n. 9, p. 1273, doi. 10.1515/cclm-2014-0564
- By:
- Publication type:
- Article
3
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. 955, doi. 10.1002/ajh.23546
- By:
- Publication type:
- Article
4
Treatment of hemophilia B: focus on recombinant factor IX.
- Published in:
- Biologics: Targets & Therapy, 2013, v. 7, p. 33, doi. 10.2147/BTT.S31582
- By:
- Publication type:
- Article
5
Recombinant activated factor VII in clinical practice: a 2014 update.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2015, v. 39, n. 2, p. 235, doi. 10.1007/s11239-014-1114-1
- By:
- Publication type:
- Article
6
ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2014, v. 38, n. 1, p. 30, doi. 10.1007/s11239-013-0995-8
- By:
- Publication type:
- Article
7
Dabigratan-related acute agranulocytosis.
- Published in:
- Blood Transfusion (17232007), 2019, v. 17, n. 2, p. 163, doi. 10.2450/2019.0237-18
- By:
- Publication type:
- Article
8
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.
- Published in:
- Blood Transfusion (17232007), 2015, v. 13, n. 3, p. 396, doi. 10.2450/2014.0242-14
- By:
- Publication type:
- Article